logo-loader
NASDAQ:NKTR

Nektar Therapeutics

Receive alerts
Market:
NASDAQ
Price
32.93 USD
Day Change
-4.33%
Market Cap:
$1.13 b
52 weeks high
108.95
52 weeks low
32.89

In brief

Nektar Therapeutics is a leading biopharmaceutical company developing a pipeline of novel therapeutics based on its advanced polymer conjugate chemistry technology platform.

Nektar also partners with the top biopharmaceutical companies to bring new products to market. To date, Nektar's technology and drug development expertise have enabled nine approved products for partners, which include leading biopharmaceutical companies.